作者：
Nina,Streefkerk [1]
;
Lisanne C E,Fioole [2]
;
Josien G M,Beijer [1]
;
Elizabeth Lieke A M,Feijen [2]
;
Jop C,Teepen [1]
;
Jeanette F,Winther [2]
;
Cecile M,Ronckers [2]
;
Jaqueline J,Loonen [3]
;
Eline,van Dulmen-den Broeder [2]
;
Rod,Skinner [4]
;
Melissa M,Hudson [2]
;
Wim J E,Tissing [5]
;
Joke C,Korevaar [6]
;
Renée L,Mulder [7]
;
Leontine C M,Kremer [2]
作者单位：
Department of Pediatric Oncology and Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
[1]
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
[2]
Department of Clinical Sciences, Pediatric Oncology and Hematology, Skåne University Hospital, Lund University, Lund, Sweden.
[3]
Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
[4]
Department of Pediatric Oncology/Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
[5]
Department of Paediatric and Adolescent Haematology and Oncology and Children's BMT Unit, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
[6]
Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
[7]
Department of Pediatric Oncology/Hematology, Beatrix Children's Hospital/University of Groningen/University Medical Center Groningen, Groningen, The Netherlands.
[8]
Netherlands Institute for Health Services Research, Utrecht, The Netherlands.
[9]
DOI
10.1002/pbc.28611
PMID
32881287
发布时间
2021-01-19
换一批
换一批
